(Q43598789)

25 November 2017

The effect of hemolysis on plasma oxidation and nitration in patients with sickle cell disease (English)

1 reference

25 November 2017

0 references

Alphan Kupesiz

1

1 reference

25 November 2017

Gamze Celmeli

2

1 reference

25 November 2017

Serdar Dogan

3

1 reference

25 November 2017

Bulent Antmen

4

1 reference

25 November 2017

Mutay Aslan

5

1 reference

25 November 2017

3 May 2012

1 reference

25 November 2017

Free Radical Research

1 reference

25 November 2017

46

1 reference

25 November 2017

7

1 reference

25 November 2017

883-890

1 reference

Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management

25 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Role of extracellular hemoglobin in thrombosis and vascular occlusion in patients with sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Redox-dependent impairment of vascular function in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Diffusion-limited reaction of free nitric oxide with erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Diagnosis of hemoglobinopathies: electrophoresis vs. HPLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Fetal hemoglobin in sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Structural bases of the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Novel permeability characteristics of red blood cells from sickle cell patients heterozygous for HbS and HbC (HbSC genotype).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Methods for the separation of lactate dehydrogenases and clinical significance of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Pathophysiology of stroke in sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Fatal sickle cell crisis after granulocyte colony-stimulating factor administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Modulation of redox pathways in neutrophils from sickle cell disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Alpha-lipoic acid modifies oxidative stress parameters in sickle cell trait subjects and sickle cell patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Nitrogen metabolism in sickle cell anemia: free amino acids in plasma and urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Is *NO news bad news in acute respiratory distress syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Hypercapnia via reduced rate and tidal volume contributes to lipopolysaccharide-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Myeloperoxidase, a leukocyte-derived vascular NO oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Interaction of nitrite with proteins at gastric pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

Increased F2Isoprostanes in the Acute Chest Syndrome of Sickle Cell Disease as a Marker of Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2012.686037

10.3109/10715762.2012.686037

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference